Search
Sumario de resultados
TIpos de contenido
Fecha
-
Press releaseBlue Biotechnology: Challenges and Opportunities in a Sector with the Capacity to Address ...
Blue biotechnology is positioned as one of the emerging sectors within the so-called Blue Economy, a key element for the European Commission to achieve goals such as those outlined in the European
-
NewAseBio expresses concern about Spain's ability to certify medical devices
In the case of Spain, we have the National Certification Center for Medical Devices as a notified body for medical devices under Regulation (EU) 2017/745, but it has not been designated for Regulation
-
Press release
AseBio expresses concern about Spain's ability to certify medical devices
The current scenario shows a worrying bottleneck with a detriment to innovative biotech products, indefinitely delaying their access to the market. Currently in Europe only 12 conformity assessment
-
NewFrom the pharmaceutical and food industries to guarantor of planetary sustainability: the ...
The vast diversity of resources provided by the still greatly unknown marine ecosystem has significant applications in fields such as food, cosmetics, fertilizers and biostimulants, biomaterials
-
NewBCN HEALTH publishes a study evaluating hospital incidence and medical costs associated wi...
BCN HEALTH publica un estudio en la revista Plos ONE sobre los datos de incidencia a nivel hospitalario y los costes médicos asociados del cáncer de próstata en España.
-
NewA gender perspective in health care help improve women's health
La ‘I Jornada Genusal. Impulsando la perspectiva de género en salud’ trató las diferencias de salud según el género, poniendo de manifiesto la necesidad de las mujeres y evitar los sesgos de sexo que
-
NewAseBio expects new improvements in the EU Pharmaceutical Legislation proposal that ensure ...
MEPs adopted their proposals to renew EU pharmaceutical legislation, promote innovation, and enhance the security of supply, accessibility, and affordability of medicines.
-
NewSmart Health Awareness' boosts awareness of AI and Big Data in the healthcare sector durin...
During last January, Merck, IBM and the University of Navara-Tecnun presented a new edition of 'Smarth Health Awareness', the training program aimed for healthcare professionals and managers on AI and
-
NewEngrail Therapeutics Closes Oversubscribed $157M Series B Financing Round to Advance the ...
Ysios Capital participates in the financing round for the capital increase of the US company Engrail Therapeutics.
-
NewTelum Therapeutics appoints Dr. Subhendu Basu as CEO
Subhendu Basu replaces Roberto Diez-Martinez in the position, who becomes Chief Operating Officer.
-
NewAseBio will actively participate in Transfiere, the largest European event on R&D&I and kn...
AseBio, from March 20 to 22, will participate in Transfiere, the largest European event on R&D&I and knowledge transfer European Forum for Science, Technology and Innovation.
-
-
-
NewThe commercial corporation of advanced therapies, an opportunity to leverage Spanish devel...
The Spanish biotech industry is present throughout the value chain of advanced therapy development and manufacturing, with 47 entities working in this field. Over 30 biotechnology companies have
-
Press release
The commercial corporation of advanced therapies, an opportunity to leverage Spanish devel...
With the creation of this commercial corporation, it is expected to "bring two advanced therapies to authorization and commercialization in 2027 manufactured in Spain." The Spanish biotech industry is
-
NewBiotechnology to reduce the risk of kidney transplant failure and adverse events related t...
On the occasion of World Kidney Day, we interviewed Isabel Portero, founder and CEO of Biophope, a biotechnology company focused on precision medicine in the areas of immunosuppression and autoimmune
-
NewAseBio, AESEMI, Cotec Foundation, and Secpho celebrate the launch by the Ministry of Scien...
The future Deep Tech Strategy takes up the challenge of the proposal for the creation of a High Commissioner for Deep Strategic Technologies made jointly by the four entities.
-
Press release
AseBio, AESEMI, Cotec Foundation, and Secpho celebrate the launch by the Ministry of Scien...
The future Deep Tech Strategy takes up the challenge of the proposal for the creation of a High Commissioner for Deep Strategic Technologies made jointly by the four entities. We consider that the
-
NewMahana Therapeutics acquires Cara Care (Asabys) to become a global platform for digital th...
The combination creates a global company that offers the most comprehensive digestive health portfolio available today.
-
EventGlobal DAO Congress
DR Healthcare launches the III edition of the Global DAO Congress (#DAO24), an event on the field of Diamine Oxidase enzyme research and management, which will be held on April 11, 2024 and can be
-
NewAbilityPharma closes €7 million round for metastatic pancreatic cancer drug ABTL0812
AbilityPharma closes €7 million round to fully fund its international Phase 2b clinical trial with the antitumor drug ABTL0812 in pancreatic cancer patients.
